Thorac Cardiovasc Surg 2008; 56(7): 428-430
DOI: 10.1055/s-2008-1038351
Short Communications

© Georg Thieme Verlag KG Stuttgart · New York

Beating Heart Valve Surgery Using Stentless Xenografts as a Surgical Alternative for Patients with End-Stage Renal Failure

M. Horst1 , J. Easo1 , P. P. Hölzl1 , O. E. Dapunt1
  • 1Department of Cardiothoracic Surgery, Klinikum Oldenburg, Oldenburg, Germany
Further Information

Publication History

Received October 17, 2007

Publication Date:
22 September 2008 (online)

Introduction

Patients suffering from end-stage renal disease are an inhomogeneous high-risk group with substantial perioperative mortality and morbidity when undergoing cardiac surgical procedures [1], [2], [3]. Myocardial ischemia, reperfusion injury and myocardial edema are a few of the deleterious consequences of the traditional use of cardioplegic arrest when performing valve surgery, irrespective of type of cardioplegia used [4], [5], [6], [7]. Novel operative techniques are required to reduce these induced perioperative risks. Clinical studies in the past have demonstrated the efficacy of beating heart valve surgery in the high-risk patient using retrograde, antegrade or combined coronary perfusion with warm oxygenated blood [8], [9]. We chose to combine the superior hemodynamic profile of stentless xenografts and the concept of performing valve replacement on the empty beating heart with a continuous antegrade application of oxygenated blood in two chronic hemodialysis patients.

References

  • 1 Horst M, Mehlhorn U, Hoerstrup S P, Suedkamp M, de Vivie E R. Cardiac surgery in patients with end-stage renal disease: 10-year experience.  Ann Thorac Surg. 2000;  69 96-101
  • 2 Brinkman W T, Williams W H, Guyton R A, Jones E L, Craver J M. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection.  Ann Thorac Surg. 2002;  74 37-42
  • 3 Mehlhorn U, Allen S J, Adams D L, Davis K L, Gogola G R, Warters R D. Cardiac surgical conditions induced by beta-blockade: effect on myocardial fluid balance.  Ann Thorac Surg. 1996;  62 143-150
  • 4 Matsumoto Y, Watanabe G, Endo M, Sasaki H, Kasashima F, Kosugi I. Efficacy and safety of on-pump beating heart surgery for valvular disease.  Ann Thorac Surg. 2002;  74 678-683
  • 5 Gersak B. A technique for aortic valve replacement on the beating heart with continuous retrograde coronary sinus perfusion with warm oxygenated blood.  Ann Thorac Surg. 2003;  76 1312-1314
  • 6 Kaplon R J, Pham S M, Salerno T A. Beating-heart valvular surgery: a possible alternative for patients with severely compromised ventricular function.  J Card Surg. 2002;  17 170-172
  • 7 Masroor S, Lombardi P, Tehrani H, Yassin S F, Katariya K, Salerno T A. Beating-heart valve surgery in patients with renal failure requiring hemodialysis.  J Heart Valve Dis. 2004;  13 302-306
  • 8 Agodoa L Y, Jones C A, Held P J. End-stage renal disease in the USA: data from the United States Renal Data System.  Am J Nephrol. 1996;  16 7-16
  • 9 Melina G, Horkaew P, Amrani M, Rubens M B, Yacoub M H, Yang G Z. Three dimensional in vivo characterization in native valves and in Freestyle versus homograft aortic valves.  J Thorac Cardiovasc Surg. 2005;  130 564-565

Dr. Jerry Easo

Klinikum Oldenburg
Department of Cardiothoracic Surgery

Dr. Eden Str. 10

26133 Oldenburg

Germany

Phone: + 49 44 14 03 28 20

Fax: + 49 44 14 03 28 30

Email: jerryeaso@hotmail.com